Catalyst Wire Dossier Catalyst Wire Dossier

Ambroxol lozenge 20 mg

ambroxol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ambroxol lozenge 20 mg, covering 2017-12-28 to 2017-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis [Phase 3]

See pricing